Report of Foreign Issuer (6-k)
May 09 2017 - 1:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN
PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2017
Commission File Number 001-37381
MEDIGUS
LTD.
(Translation of registrant’s name into English)
Omer
Industrial Park, No. 7A, P.O. Box 3030, Omer 8496500, Israel
(Address of principal executive
offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F
☒
Form
40-F
☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY NOTE
On
May 9, 2017, Medigus Ltd. issued a press release titled: “Medigus Presents New Data Demonstrating the MUSE™ System
Improves GERD Symptoms and Reduces Proton Pump Inhibitor Reliance.” A copy of this press release is furnished herewith as
exhibit 99.1.
This
Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3 filed with the U.S. Securities
and Exchange Commission on August 24, 2016 (Registration No. 333-213280) and its Registration Statement on Form S-8 filed with
the U.S. Securities and Exchange Commission on September 9, 2015 (Registration No. 333-206803).
SIGNATURE
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MEDIGUS LTD.
|
|
|
|
Date: May 9, 2017
|
By:
|
/S/ Oded Yatzkan
|
|
|
Oded Yatzkan
|
|
|
Chief Financial Officer
|
EXHIBIT INDEX
- 4 -
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Sep 2023 to Sep 2024